Clinical Therapeutics
Vol 36 | No. 1 | 01 January 2014 | Pages 1-150
http://www.clinicaltherapeutics.com/current

Safety and Success of the Human Papillomavirus Vaccine: Time for a Robust Vaccination Program in the United States and Worldwide
Linda R. Duska, MD
http://www.clinicaltherapeutics.com/article/S0149-2918%2813%2901102-8/fulltext
Excerpt
…Education, then, is key. Education of health care professionals, particularly pediatricians, and parents about the tolerability and efficacy of this vaccine is crucial to increasing uptake. Vaccination of both boys and girls before the initiation of sexual activity is critical to optimal protection against HPV infection and its sequelae. Perhaps most importantly, we must educate those people in power who influence health policy decisions and may erroneously believe that the HPV vaccine will somehow condone sexually activity in our children.

Update on Vaccination Clinical Trials for HPV-Related Disease  
Britt K. Erickson, Emily E. Landers, Warner K. Huh
Abstract

The Australian Experience With the Human Papillomavirus Vaccine  
Suzanne M. Garland
Abstract

Race, Ethnicity, and Income Factors Impacting Human Papillomavirus Vaccination rates  

Patricia Jeudin, Elizabeth Liveright, Marcela G. del Carmen, Rebecca B. Perkins
Abstract